U.S. Markets open in 3 hrs 52 mins
  • S&P Futures

    4,137.25
    +4.50 (+0.11%)
     
  • Dow Futures

    33,579.00
    +9.00 (+0.03%)
     
  • Nasdaq Futures

    13,995.00
    +19.25 (+0.14%)
     
  • Russell 2000 Futures

    2,228.60
    +3.70 (+0.17%)
     
  • Crude Oil

    61.18
    +1.00 (+1.66%)
     
  • Gold

    1,743.50
    -4.10 (-0.23%)
     
  • Silver

    25.43
    +0.01 (+0.04%)
     
  • EUR/USD

    1.1957
    +0.0003 (+0.0239%)
     
  • 10-Yr Bond

    1.6230
    0.0000 (0.00%)
     
  • Vix

    16.66
    -0.25 (-1.48%)
     
  • GBP/USD

    1.3775
    +0.0023 (+0.1639%)
     
  • USD/JPY

    108.9940
    -0.0540 (-0.0495%)
     
  • BTC-USD

    63,410.00
    +731.47 (+1.17%)
     
  • CMC Crypto 200

    1,363.01
    +69.02 (+5.33%)
     
  • FTSE 100

    6,905.39
    +14.90 (+0.22%)
     
  • Nikkei 225

    29,620.99
    -130.62 (-0.44%)
     

BSX, NERV & SMICY Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Shareholders to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / January 19, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Boston Scientific Corporation (NASDAQ:BSX)
Class Period:
April 24, 2019 - November 16, 2020
Deadline: February 3, 2021
For more info: www.bgandg.com/bsx

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the LOTUS Edge Aortic Valve System's product delivery system was dysfunctional and threatened the continued viability of the entire product line; (2) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times.

Minerva Neurosciences, Inc. (NASDAQ:NERV)
Class Period:
May 15, 2017 - November 30, 2020
Deadline: February 8, 2021
For more info: www.bgandg.com/nerv

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the truth about the feedback received from the FDA concerning the "end-of-Phase 2" meeting; (2) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (3) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (4) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be "highly unlikely" to support the submission of an NDA; (5) reliance on these two trials in the submission of an NDA would lead to "substantial review issues" because the trials were inadequate and not well-controlled; and (6) as a result, the Minerva's public statements were materially false and misleading at all relevant times.

Semiconductor Manufacturing International Corporation (OTCQX:SMICY)
Class Period:
April 23, 2020 - September 26, 2020
Deadline: February 8, 2021
For more info: www.bgandg.com/smicy

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) there was an "unacceptable risk" that equipment supplied to SMIC would be used for military purposes; (2) SMIC was foreseeably at risk of facing U.S. restrictions; (3) as a result of restrictions by the U.S. Department of Commerce, certain of SMIC's suppliers would need "difficult-to-obtain" individual export licenses; and (4) as a result, defendants' public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/624501/BSX-NERV-SMICY-Class-Actions-Bronstein-Gewirtz-Grossman-LLC-Reminds-Investors-of-Class-Actions-and-Encourages-Shareholders-to-Contact-the-Firm